These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Particulate contrast media for computed tomographic scanning of the liver. Violante MR; Dean PB; Fischer HW; Mahoney JA Invest Radiol; 1980; 15(6 Suppl):S171-5. PubMed ID: 7203919 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and clinical studies of ioglicinate, a new contrast medium for intravenous urography. Nagel R; Leistenschneider W; Speck U; Clauss W Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):49-53. PubMed ID: 631971 [TBL] [Abstract][Full Text] [Related]
6. Identification of proteins adsorbed from human plasma to glass bead columns: plasmin-induced degradation of adsorbed fibrinogen. Brash JL; Thibodeau JA J Biomed Mater Res; 1986; 20(9):1263-75. PubMed ID: 2946694 [TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced CT of the liver and spleen: comparison of ionic and nonionic contrast agents. Nelson RC; Chezmar JL; Peterson JE; Bernardino ME AJR Am J Roentgenol; 1989 Nov; 153(5):973-6. PubMed ID: 2801447 [TBL] [Abstract][Full Text] [Related]
8. The effect of ionic and nonionic contrast media on the sickling phenomenon. Rao VM; Rao AK; Steiner RM; Burka ER; Grainger RG; Ballas SK Radiology; 1982 Jul; 144(2):291-3. PubMed ID: 7089282 [TBL] [Abstract][Full Text] [Related]
9. Colloidal stannic oxide; animal studies on a new hepatolienographic agent. FISCHER HW Radiology; 1957 Apr; 68(4):488-98. PubMed ID: 13432176 [No Abstract] [Full Text] [Related]
10. Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress. Rao AK; Rao VM; Willis J; Beckett C; Steiner RM Radiology; 1985 Aug; 156(2):311-3. PubMed ID: 4011893 [TBL] [Abstract][Full Text] [Related]
11. Fluid compartment distribution of intravenous iothalamate in the dog. Newhouse JH Invest Radiol; 1977; 12(4):364-7. PubMed ID: 885695 [TBL] [Abstract][Full Text] [Related]
13. Contrast agent induced thrombophlebitis following leg phlebography: iopamidol versus meglumine iothalamate. Lea Thomas M; Keeling FP; Piaggio RB; Treweeke PS Br J Radiol; 1984 Mar; 57(675):205-7. PubMed ID: 6365232 [TBL] [Abstract][Full Text] [Related]
14. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots. Carr ME; Carr SL; Merten SR Haemostasis; 1995; 25(4):172-81. PubMed ID: 7557656 [TBL] [Abstract][Full Text] [Related]
15. Biliary contrast agents: comparative study about the binding to human plasma and the effect of human plasma on hepatic uptake. Müller WE; Stillbauer AE Pharmacology; 1981; 22(4):269-75. PubMed ID: 7267698 [TBL] [Abstract][Full Text] [Related]
16. [Effect of a new non-ionic contrast medium on left ventricular volume measurements in the dog]. Fappani A; Di Donato M; Bongrani S; Baldi G; Effendy FN; Cucchini F Boll Soc Ital Cardiol; 1978; 23(3):550-8. PubMed ID: 753363 [No Abstract] [Full Text] [Related]
17. Renal toxicity of contrast agents: iopamidol, iothalamate, and diatrizoate. Gale ME; Robbins AH; Hamburger RJ; Widrich WC AJR Am J Roentgenol; 1984 Feb; 142(2):333-5. PubMed ID: 6607603 [TBL] [Abstract][Full Text] [Related]
18. Particle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicology. Kendall M; Ding P; Kendall K Nanotoxicology; 2011 Mar; 5(1):55-65. PubMed ID: 21417688 [TBL] [Abstract][Full Text] [Related]
19. Differential plasma protein binding to metal oxide nanoparticles. Deng ZJ; Mortimer G; Schiller T; Musumeci A; Martin D; Minchin RF Nanotechnology; 2009 Nov; 20(45):455101. PubMed ID: 19822937 [TBL] [Abstract][Full Text] [Related]
20. Improvement in radiographic contrast media through the development of colloidal or particulate media: an analysis. Fischer HW J Theor Biol; 1977 Aug; 67(4):653-70. PubMed ID: 333187 [No Abstract] [Full Text] [Related] [Next] [New Search]